Hem › Multipelt myelom › Kentucky › Louisville
Kliniska studier för Multipelt myelom i Louisville, KY
12 studier för Multipelt myelom söker deltagare vid platser i och runt Louisville (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekryterarFas 3
- Research Site, Louisville
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 3
- Norton Cancer Institute, Louisville
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 3
- Norton Cancer Institute, Louisville
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 2
- Norton Cancer Institute, Louisville
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekryterarFas 3
- Norton Cancer Institute, Louisville
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
RekryterarFas 1/2
- Norton Healthcare, Inc., Louisville
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 2
- Norton Women's and Children's Hospital, Louisville
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekryterarFas 3
- Research Site, Louisville
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekryterarFas 1
- Norton Cancer Institute St. Matthews, Louisville
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
RekryterarFas 1/2
- Norton Cancer Institute, Louisville
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
RekryterarFas 1/2
- Norton Cancer Institute, Louisville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekryterarObservationsstudieFriska volontärer välkomna
- Baptist Floyd, New Albany · 4 mi bort
Multipelt myelom-studier i andra städer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA42 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Edison, NJ22 studier
Andra studier i Louisville
- Icke-småcellig lungcancer22 studier
- Övervikt17 studier
- Övervikt15 studier
- Cancer (alla typer)14 studier
- Hjärtsvikt13 studier
- Akut myeloid leukemi12 studier
- Äggstockscancer12 studier
- Bröstcancer11 studier
- Plattenepitelcancer i huvud och hals11 studier
- Lungcancer11 studier
- Melanom10 studier
- Prostatacancer10 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.